HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations ...

BeiGene, Ltd. , a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share 23 abstracts featuring new data across its hematology and solid tumor ...

Studying mice that had tumors induced in the brain, blood, skin and bone, the scientists wanted to understand the influence on cognition of CAR-T cell treatment in combination with the tumors ...

They studied mice that had tumors induced in the brain, blood, skin and bone. The researchers wanted to understand the influence on cognition of CAR-T cell treatment in combination with the tumors ...

Mantle cell lymphoma grows slowly but can be hard to treat. In this type of lymphoma, small cells grow slowly in places called marginal zones. These places could be in your stomach, skin ...

including cutaneous T-cell lymphoma (CTCL). CTCL is a rare and aggressive form that originates in T-lymphocytes residing in the skin. It typically manifests with persistent skin lesions ...

For instance, the first signs of a type of T-cell lymphoma called mycosis fungoides is often a skin rash, while other forms may present with swollen lymph nodes. Acquired genetic mutations usually ...

The most common adverse reactions reported in patients treated with brentuximab vedotin plus lenalidomide/rituximab were fatigue, diarrhea, peripheral neuropathy, rash ... cell lymphoma and ...

13, 2025 -- The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma ... pain or numbness, skin rash, pneumonia ...